Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.4

The market opened in green on November 17, 2020, overall volumes in futures & options currently stand at 33,24,896 contracts with a turnover of Rs. 2,57,976.92 crore.

Indian markets to continue their bull run on back of positive covid-19 vaccine trial results!
Indian markets to continue their bull run on back of positive covid-19 vaccine trial results!

Indian markets to continue their bull run on back of positive covid-19 vaccine trial results!

Karan Dsij Article rating: 4.7

The Indian markets logged a fresh high record closing in the short one-hour Diwali Muhurat trading session on Saturday. Though the Diwali festive is behind us, but the bulls are likely to continue their fireworks On Tuesday as the global peers are trading buoyant after the news emerged that Moderna’s vaccine candidate has proven to be 94.5 per cent effective in preventing Covid-19 infection.

Sensex, Nifty in green; Adani Green locks in at upper circuit, Jubilant FoodWorks jumps 6 per cent, Bharat Forge tumbles
Sensex, Nifty in green; Adani Green locks in at upper circuit, Jubilant FoodWorks jumps 6 per cent, Bharat Forge tumbles

Sensex, Nifty in green; Adani Green locks in at upper circuit, Jubilant FoodWorks jumps 6 per cent, Bharat Forge tumbles

Geyatee Deshpande Article rating: 3.9

Ahead of Muhurat Trading session, the domestic benchmark indices closed in the green on Friday. Sensex gained by 85.81 points or 0.20 per cent to settle at 43,443 levels while Nifty closed up by 29.15 points or 0.23 per cent at 12,719.95 levels.

Natco Pharma receives USFDA nod for Pomalidomide
Natco Pharma receives USFDA nod for Pomalidomide

Natco Pharma receives USFDA nod for Pomalidomide

Anthony Fernandes Article rating: 4.0

On Friday, Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc., has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide capsules, from United States Food & Drug Administration (USFDA).

Top small-cap & mid-cap performers since last Diwali
Top small-cap & mid-cap performers since last Diwali

Top small-cap & mid-cap performers since last Diwali

Geyatee Deshpande Article rating: 3.7

Small-cap and mid-cap stocks have been the highlight of 2020. Being one of the investors’ most preferred choices of scrips, below are some of the small-cap and mid-cap stocks, which have outperformed Sensex since last Diwali and have spread happiness among investors by giving significantly high returns.

Multibagger stocks since Muhurat Trading 2019: Are these stocks in your portfolio?
Multibagger stocks since Muhurat Trading 2019: Are these stocks in your portfolio?

Multibagger stocks since Muhurat Trading 2019: Are these stocks in your portfolio?

Geyatee Deshpande Article rating: 3.8

Generally, Indian stock exchanges hold a special symbolic trading session which is a one-hour session on the occasion of Diwali. Known as Muhurat Trading, it is considered auspicious to symbolise the beginning of the traditional Hindu accounting year, ‘Samvat’.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 4.1

The market opened in red on November 13, 2020, overall volumes in futures & options currently stand at 7,06,70,316 contracts with a turnover of Rs. 55,31,324.77 crore.

RSS
First19291930193119321934193619371938Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR